Nonpalpable invasive breast cancer

Comment

J S Spratt. Ann Surg. 1992 Jan.

. 1992 Jan;215(1):89.

No abstract available

Comment on

Nonpalpable invasive breast cancer.
Wilhelm MC, Edge SB, Cole DD, deParedes E, Frierson HF Jr. Wilhelm MC, et al. Ann Surg. 1991 Jun;213(6):600-3; discussion 603-5. doi: 10.1097/00000658-199106000-00010. Ann Surg. 1991. PMID: 2039291 Free PMC article.

Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E. Lynge E. APMIS Suppl. 1998;83:1-44. APMIS Suppl. 1998. PMID: 9850674
The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
Hofvind S, Thoresen S, Tretli S. Hofvind S, et al. Cancer. 2004 Oct 1;101(7):1501-7. doi: 10.1002/cncr.20528. Cancer. 2004. PMID: 15378474
Results from a multidisciplinary breast center. Analysis of disease discovered.
Silverstein MJ, Gamagami P, Masetti R, Legmann MD, Craig PH, Gierson ED. Silverstein MJ, et al. Surg Oncol Clin N Am. 1997 Apr;6(2):301-14. Surg Oncol Clin N Am. 1997. PMID: 9115497
Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer.
Lind DS, Minter R, Steinbach B, Abbitt P, Lanier L, Haigh L, Vauthey JN, Russin M, Hackett R, Copeland EM. Lind DS, et al. J Surg Res. 1998 Jul 15;78(1):23-6. doi: 10.1006/jsre.1998.5380. J Surg Res. 1998. PMID: 9733612
Management of clinically occult (nonpalpable) breast lesions.
Schwartz GF, Feig SA. Schwartz GF, et al. Obstet Gynecol Clin North Am. 1994 Dec;21(4):621-37. Obstet Gynecol Clin North Am. 1994. PMID: 7731638 Review.